Abstract
Administration of di-n-propylacetate (DPA), an inhibitor of SSA-dehydrogenase, produces in naive rats abstinence behaviour which can be blocked by morphine and bicuculline and may be useful as a behavioural correlate of increased GABA-ergic activity. The usefulness of this model has been demonstrated by studying the effec of bicuculline, picrotoxin, strychnine, morphine, aminooxyacetic acid, 3-mercaptopropionate and thiosemicarbazide on DPA-induced abstinence behaviour. Behaviour was suppressed both by bicuculline or picrotoxin, while the selective glycine antagonist strychnine was ineffective. A comparable syndrome could not be evoked by treatment with aminooxyacetic acid, a GABA-transaminase inhibitor, indicating that the effect of DPA was not caused by inhibition of this enzyme. Instead, aminooxyacetic acid suppressed the DPA-induced abstinence behaviour, suggesting that two GABA-ergic systems with opposite effects on behaviour can be distinguished. The syndrome was also suppressed by convulsant doses of 3-mercaptopropionate, while thiosemicarbazide was ineffective. Abstinence behaviour was further suppressed by morphine with an ED50 of 0.5 mg/kg and this action could be clearly separated from its depressant effect on locomotor activity in non-treated animals. These results suggest that morphine receptors may be involved in DPA-induced abstinence behaviour. Based on these experiments a model has been proposed for GABA-ergic terminals being under the inhibitory influence of GABA-ergic autoreceptors. It is proposed that DPA-induced abstinence behaviour may be useful as a model of increased GABA-ergic activity to aid study of the regulation and properties of the GABA-ergic system in vivo.
Similar content being viewed by others
References
Anlezark G, Horton RW, Meldrum BS, Sawaya MCB (1976) Anticonvulsant action of ethanolamine-O-sulphate and di-n-propylacetate and the metabolism of γ-aminobutyric acid (GABA) in mice with audiogenic seizures. Biochem. Pharmacol. 25:413–417
Ayhan IH (1974) Daily susceptibility variations to the morphine-induced hyperactivity of rats. J Pharm Pharmacol 26:76–78
Balázs R, Patel AJ, Richter D (1972) Metabolic compartmentation in the brain: their properties and relation to morphological structures. In: Balazs R, Cremer JE (eds) Metabolic compartmentation in the brain. Macmillan, London, p 167
Baxter CF (1976) Some recent advances in studies of GABA metabolism and compartmentation. In: Roberts E, Chase TN, Tower DB (eds) GABA in nervous tissue function. Raven, New York, p 61
Biggio G, Della Bella D, Frigeni V, Guidotti A (1977) Potentiation of morphine analgesia by muscimol. Neuropharmacology: 16:149–150
Christensen AV, Arut J, Scheel-Kruger J (1978) Muscimol antagonizes morphine hypermotility without potentiation of analgesia. Eur J Pharmacol 48:459–462
Ciesielski L, Maitre M, Cash C, Mandel P (1975) Regional distribution in brain and effect on cerebral mitochondrial respiration of the antoconvulsive drug n-Di-propylacetate. Biochem Pharmacol 24:1055–1058
Collier MOJ, Francis DL (1975) Morphine abstinence is associated with increased brain cAMP. Nature 255:159–162
Cowan A, Watson T (1978) Lysergic acid di-ethylamide antagonizes shaking induced in rats by five chemically different compounds. Psychopharmacology 57:43–46
Curtis DR, Johnston GAR (1973) Amino acid transmitters in the mammalian central nervous system. Ergeb Physiol 69:97–188
De Boer T (1977) GABA shunt enzymes and the relationship with morphine abstinence. Thesis, Rotterdam
De Boer T, Bruinvels J (1977) Assay and properties of 4-aminobutyric-2-oxoglutaric acid transaminase and succinic semialdehyde dehydrogenase in rat brain tissue. J Neurochem 28:471–478
De Boer T, Bruinvels J, Bonta IL (1979) Differential effects of GABA analogues and zine on glutamate decarboxylase, 4-aminobutyric-2-oxoglutaric acid trasaminase and succinic semialdehyde dehydrogenase in rat brain tissue. J Neurochem 33:597–601
De Boer T, Metselaar HJ, Bruinvels J (1977) Suppression of GABA-induced abstinence behaviour in naive rats by morphine and bicuculline. Life Sci 20:933–942
Domino EF, Vasko MR, Wilson AE (1976) Mixed depressant and stimulant actions of morphine and their relationship to brain acetylcholine. Life Sci 18:361–376
Enna SJ, Collins JF, Snyder SH (1977) Stereospecificity and structure-activity requirements of GABA receptor binding in rat brain. Brain Res 124:185–190
Fowler LJ, Beckford J, John RA (1975) An analysis of the kinetics of the inhibition of rabbit brain gamma-aminobutyrate aminotransferase by sodium-n-di-propylacetate and some other simple carboxylic acids. Biochem Pharmacol 24:126–127
Frederickson RCA, Smits SE (1973) Time course of dependence and tolerance development in rats treated with ‘slow release’ morphine suspensions. Res Commun Chem Pathol Pharmacol 5:867–870
Godin Y, Heiner L, Mark J, Mandel P (1969) Effects of di-n-propylacetate and anticonvulsive compound, on GABA metabolism. J Neurochem 16:869–873
Greenlee DV, Van Ness PC, Olsen RW (1979) Gamma-aminobutyric acid binding in mammalian brain: receptor-like specificity of sodium-independent sites. Eur J Pharmacol 59:125–129
Haber B (1973) Product inhibition of l-glutamic acid decarboxylase (GAD-I). Texas Rep Biol Med 31:311–319
Harvey PKP, Bradford HF, Davison AN (1975) The inhibitory effect of sodium N-dipropylacetate in the degradative enzymes of the GABA shunt. Febs Lett 52:251–254
Ho IK, Loh MM, Way EL (1976) Pharmacological manipulation of gamma-aminobutyric acid (GABA) in morphine analgesia, tolerance and physical dependence. Life Sci 18:1111–1124
Iadarola MJ, Gale K (1979) Dissociation between drug-induced increases in nerve terminal and non-nerve terminal pools of GABA in vivo. Eur J Pharmacol 59:125–129
Iadarola MJ, Raines A, Gale K (1979) Differential effects of N-dipropylacetate and amino-oxyacetic acid on γ-aminobutyric acid levels in discrete areas of rat brain. J Neurochem 33:1119–1123
Iwatsubo K, Kondo Y (1978) Inhibitory effect of morphine on the release of preloaded 3H-GABA from rat substantia nigra in response to the stimulation of caudate nucleus and globus pallidus. In: Van Ree J, Terenius L, (eds) Characteristics and function of opioids. Elsevier/North-Holland Biomedical Press, Amsterdam, p 357
Kaarianen I, Viking P (1976) Effects of aminooxyacetic acid and baclophen on catalepsy, striatal homovanillic acid increase and antinociception caused by methadone in rats. Acta Pharmacol Toxicol 39:536–544
Kelly JS, Beart PM (1975) Amino acid receptors in CNS. II GABA in supraspinal regions. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology, vol 4. Amino acid neurotransmitters. Plenum, New York London, p 129
Kuschinsky K, Hornykiewicz O (1972) Morphine catalepsy in the rat: relation to striatal dopamine metabolism. Eur J Pharmacol 19:119–122
Lin SC, Sutherland VC, Way EL (1973) Brain amino acids in morphine tolerant and non-tolerant rats. Proc West Pharmacol Soc 16:8–13
Lust WD, Kupferberg HJ, Yonekawa WD, Penry JK, Passonneau JV, Wheaton AB (1978) Changes in brain metabolites induced by convulsants or electroshock: effects of anticonvulsant agents. Molec Pharmacol 14:347–356
Mantegazza P, Tammiso R, Vicentini L, Zambotti F, Zonta N (1979) Muscimol antagonism of morphine analgesia in rats. Br J Pharmacol 67:103–107
Mitchell PR, Martin IL (1978) Is GABA release modulated by presynaptic receptors? Nature 274:904–906
Moroni F, Cheney DL, Peralta E, Costa E (1978) Opiate receptor agonists as modulators of γ-aminobutyric acid turnover in the Nucleus Caudatus, globus Pallidus and Substantia Nigra of the rat. J Pharmacol Exp Ther 207:870–877
Moroni F, Peralta E, Cheney DL, Costa E (1979) On the regulation of γ-aminobutyric acid neurons in Caudatus, Pallidus and Nigra: Effects of opioids and dopamine agonists. J Pharmacol Exp Ther 208:190–194
Patel AJ, Johnson AL, Balázs R (1974) Metabolic compartmentation of glutamate associated with the formation of γ-aminobutyrate. J Neurochem 23:1271–1279
Sarhan S, Seiler N (1980) Metabolic inhibitors and subcellular distribution of GABA. J Neurosci Res, in press
Simler S, Ciesielski L, Maitre M, Randrianarisoa H, Mandel P (1973) Effect of sodium n-dipropylacetate on audiogenic seizures and brain γ-aminobutyrate levels. Biochem Pharmacol 22:1701–1708
Sims KL, Davis GA (1973) Subcellular distribution of succinatesemialdehyde dehydrogenase in rat brain. Eur J Biochem 35:450–453
Siu PML, West S, Bogdanove AJ (1976) Morphine dependence in rats on a pyridoxine-deficient, a pyridoxine-repleted and a normal chow diet plus pyridoxine injections. J Neurochem 26:633–634
Tapia R (1975) Biochemical pharmacology of GABA in CNS. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology, vol 4. Amino acid neurotransmitters. Plenum, New York London, p 1
Tappaz ML, Browstein MJ, Kopin IJ (1977) Glutamate decarboxylase (GAD) and γ-aminobutyric acid (GABA) in discrete nuclei of hypothalamus and substantia nigra. Brian Res 125:109–121
Turksky T (1974) Gamma-aminobutyric acid inhibition of pyridoxal kinase activity in the rat brain. Biokhimia 39:1138–1145
Tzeng SF, Ho IK (1978) Acute and continuous morphine administration in the γ-aminobutyric acid system in the mouse. Progr Neuro-Psychopharmacol 2:55–64
Van den Berg CJ, Matheson DF, Ronda G, Reijnierse GLA, Blokhuis GGD, Kroon MC, Clarke DD, Garfunkel D (1975) A model of glutamate metabolism in brain: a biochemical analysis of a heterogeneous structure. In: Berl S, Clarke DD, Schneider D (eds) Metabolic compartmentation and neurotransmission. Plenum, New York London, p 515
Van der Heyden JAM, Venema K, Korf J (1979) In vivo release of endogenous GABA from rat substantia nigra measured by a novel method. J Neurochem 32:469–476
Van der Laan JW, De Boer T, Bruinvels J (1979a) Di-n-propylacetate and GABA degradation. Preferential inhibition of succinic semialdehyde dehydrogenase and indirect inhibition of GABA-transaminase. J Neurochem 32:1769–1780
Van der Laan JW, Jacobs AWCM, Bruinvels J (1979b) Effect of short-chain and branched-chain fatty-acids on succinic semialdehyde dehydrogenase. Abstracts of the Seventh Meeting of the International Society for Neurochemistry, Jerusalem, p 630
Van Gelder NM (1966) The effect of aminooxyacetic acid on the metabolism of γ-aminobutyric acid in brain. Biochem. Pharmacol 15:533–539
Volicer L, Puri SK, Choma P (1977) Cyclic GMP and GABA levels in rat striatum and cerebellum during morphine withdrawal: effect of apomorphine. Neuropharmacology 16:791–794
Wachtel H, Anden NE (1978) Motor activity of rats following intracerebral injections of drugs influencing GABA mechanisms. Naunyn-Schmiedeberg's Arch Pharmacol 302:133–139
Walters JR, Eng N, Pericic D, Miller LP (1978) Effects of aminooxyacetic acid and l-glutamic acid γ-hydrazide on GABA metabolism in specific brain regions. J Neurochem 30:759–766
Way EL (1973) Brain Neurohormones in Morphine Tolerance and Dependence. In: Pharmacology and the future of man. Proc 5th Int Congr Pharmacology, San Francisco, 1972, vol 1. Karger, Basel, p 77
Wood JD (1975) The role of gamma-aminobutyric acid in the mechanism of seizures. Progr Neurobiol 5:77–95
Wood JD, Peesker SJ (1973) The role of GABA metabolism in the convulsant and anticonvulsant actions of aminooxyacetic acid. J Neurochem 20:379–387
Wood JD, Durham JS, Peesker SJ (1977) Effect of di-n-propylacetate and γ-acetylenic GABA on hyperbaric oxygen-induced seizures and GABA metabolism. Neurochem Res 2:707–715
Yoneda Y, Takashima S, Kuriyama K (1976) Possible involvement of GABA in morphine analgesia. Biochem Pharmacol 25:2669–2670
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
de Boer, T., Bartels, K., Metselaar, H.J. et al. Di-n-propylacetate-induced abstinence behaviour as a possible correlate of increased GABA-ergic activity in the rat. Psychopharmacology 71, 257–267 (1980). https://doi.org/10.1007/BF00433060
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00433060